Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 24/08/20231 min de leitura
Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Alternative Form of Hearing
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) announces an alternative form of hearing regarding the Center for Drug Evaluation and Research's (CDER's) proposal to refuse to approve ITCA 650 (exenatide in DUROS device), a drug-device combination product that is the subject of a new drug application (NDA) submitted by Intarcia Therapeutics, Inc. (Intarcia). CDER is holding a public hearing before an advisory committee under FDA regulations as an alternative form of hearing.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →